Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.

from NYT > Health https://ift.tt/VSTz3oR

Related Posts:

0 comments:

Post a Comment

Popular Posts